Thus, it will be important to delineate the protective actions of IFN-γ in a cell- and timing-specific manner, especially because IFN-γ-based therapies are currently being trialed in the clinic for treatment of cryptococcal meningitis. The gene discussed is IFNG; the disease is Cryptococcal meningitis.